In response to the COVID-19 pandemic, Harvard Medical School convened the Massachusetts Consortium on Pathogen Readiness (MassCPR), a broad multi-institutional initiative that aims to turn the tide of the current pandemic and establish rapid response systems to help deal with future outbreaks.
On May 15, MassCPR held its first public briefing to provide an overview of the progress of the efforts of the hundreds of scientists, clinicians and public health experts that encompass the consortium.
In addition to the core funding provided by the China Evergrande Group, MassCPR was enabled by critical support from philanthropists and supporters, including the Massachusetts Life Sciences Center, the state’s economic development and investment agency dedicated to supporting the growth of life sciences, Mark and Lisa Schwartz, the Bertarelli Foundation and many others.